TRIB3 supports breast cancer stemness by suppressing FOXO1 degradation and enhancing SOX2 transcription

Jin-mei Yu,Wei Sun,Zhen-he Wang,Xiao Liang,Fang Hua,Ke Li,Xiao-xi Lv,Xiao-wei Zhang,Yu-ying Liu,Jiao-jiao Yu,Shan-shan Liu,Shuang Shang,Feng Wang,Zhao-na Yang,Chen-xi Zhao,Xue-ying Hou,Ping-ping Li,Bo Huang,Bing Cui,Zhuo-Wei Hu
DOI: https://doi.org/10.1038/s41467-019-13700-6
IF: 16.6
2019-12-01
Nature Communications
Abstract:Abstract The existence of breast cancer stem cells (BCSCs) is a major reason underlying cancer metastasis and recurrence after chemotherapy and radiotherapy. Targeting BCSCs may ameliorate breast cancer relapse and therapy resistance. Here we report that expression of the pseudokinase Tribble 3 (TRIB3) positively associates with breast cancer stemness and progression. Elevated TRIB3 expression supports BCSCs by interacting with AKT to interfere with the FOXO1-AKT interaction and suppress FOXO1 phosphorylation, ubiquitination, and degradation by E3 ligases SKP2 and NEDD4L. The accumulated FOXO1 promotes transcriptional expression of SOX2, a transcriptional factor for cancer stemness, which in turn, activates FOXO1 transcription and forms a positive regulatory loop. Disturbing the TRIB3-AKT interaction suppresses BCSCs by accelerating FOXO1 degradation and reducing SOX2 expression in mouse models of breast cancer. Our study provides insights into breast cancer development and confers a potential therapeutic strategy against TRIB3-overexpressed breast cancer.
multidisciplinary sciences
What problem does this paper attempt to address?